ProShares Ultra Nasdaq Biotechnology Rating $53.66 -5.31 (-9.00%) (As of 11/15/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy2.69Holdings in BIB have an aggregate rating of Moderate Buy based on 667 analyst ratings issued in the past year covering 43 companies (55.4% of the portfolio).BIB Aggregate Price Target$53.66High Prediction$53.66Average Prediction$53.66Low Prediction$53.66Holdings in BIB have an aggregate price target of $53.66 and a range of $53.66 to $53.66 covering 43 companies (55.4% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.65%GILDGilead Sciences$88.40-4.0%4.6269 of 5 stars2.68$93.86 6.2%25Analyst UpgradeShort Interest ↑News Coverage5.68%VRTXVertex Pharmaceuticals$465.70-3.8%3.5513 of 5 stars2.53$499.12 7.2%30Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume5.60%AMGNAmgen$283.61-4.2%4.9229 of 5 stars2.46$333.57 17.6%26Analyst ForecastShort Interest ↓News CoveragePositive NewsHigh Trading Volume4.65%REGNRegeneron Pharmaceuticals$756.81-3.3%4.8088 of 5 stars2.78$1,099.55 45.3%23Analyst UpgradeNews Coverage3.13%AZNAstraZeneca$63.23-2.8%4.1705 of 5 stars3.00$89.75 41.9%11Earnings ReportShort Interest ↑2.62%ALNYAlnylam Pharmaceuticals$235.56-8.7%4.8186 of 5 stars2.71$294.50 25.0%24Analyst DowngradeShort Interest ↓1.89%BIIBBiogen$159.99-3.0%4.8908 of 5 stars2.57$258.96 61.9%28Analyst UpgradeNews Coverage1.62%ILMNIllumina$135.05-5.1%4.3793 of 5 stars2.67$164.00 21.4%24Analyst ForecastPositive NewsHigh Trading Volume1.46%MRNAModerna$36.85-7.3%4.5668 of 5 stars2.05$90.22 144.8%21Analyst ForecastOptions VolumeGap DownHigh Trading Volume1.28%ARGXargenx$564.23-5.2%2.8645 of 5 stars2.91$619.79 9.8%23Analyst UpgradeGap DownHigh Trading Volume1.14%SNYSanofi$47.97+0.3%2.8526 of 5 stars2.75$57.50 19.9%4Analyst Revision1.11%UTHRUnited Therapeutics$363.25-6.0%4.5219 of 5 stars2.73$370.86 2.1%15Insider SellingNews CoveragePositive News1.10%SMMTSummit Therapeutics$18.31-5.9%2.2053 of 5 stars2.75$34.75 89.8%4Gap Up0.98%VTRSViatris$12.83+1.7%1.3744 of 5 stars2.00$13.33 3.9%3Insider Selling0.95%BMRNBioMarin Pharmaceutical$63.42-3.3%4.987 of 5 stars2.74$94.20 48.5%23Analyst ForecastInsider SellingNews Coverage0.90%PCVXVaxcyte$86.83-6.3%3.3342 of 5 stars3.00$147.50 69.9%7News CoverageHigh Trading Volume0.90%INCYIncyte$75.87-2.4%4.1889 of 5 stars2.38$77.16 1.7%21Analyst ForecastPositive News0.89%SRPTSarepta Therapeutics$104.54-4.2%4.929 of 5 stars3.00$181.33 73.5%22Analyst Upgrade0.87%INSMInsmed$66.29-7.0%4.3872 of 5 stars3.00$83.07 25.3%16Positive NewsHigh Trading Volume0.86%RPRXRoyalty Pharma$25.70+1.3%4.7879 of 5 stars2.83$41.67 62.1%6Positive News0.84%NBIXNeurocrine Biosciences$117.44-4.4%4.9652 of 5 stars2.83$163.91 39.6%24Positive News0.77%BNTXBioNTech$99.72-3.7%3.5042 of 5 stars2.79$137.54 37.9%14Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap DownHigh Trading Volume0.73%MEDPMedpace$310.63-7.2%4.7466 of 5 stars2.45$380.00 22.3%11High Trading Volume0.67%BGNEBeiGene$189.23-2.1%3.0621 of 5 stars2.71$247.07 30.6%7Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage0.63%ROIVRoivant Sciences$11.20-3.8%3.4265 of 5 stars2.88$17.93 60.1%8Analyst ForecastNews CoverageHigh Trading Volume0.57%EXELExelixis$34.45-1.7%4.8159 of 5 stars2.65$31.44 -8.7%20Short Interest ↓Positive News0.57%ITCIIntra-Cellular Therapies$83.42-4.8%4.5171 of 5 stars2.85$97.23 16.6%13Insider SellingPositive News0.55%RVMDRevolution Medicines$55.13-3.9%3.5636 of 5 stars3.08$61.00 10.6%120.54%ASNDAscendis Pharma A/S$126.51+1.8%3.0664 of 5 stars2.92$191.77 51.6%13Analyst DowngradeShort Interest ↑News CoverageHigh Trading Volume0.48%JAZZJazz Pharmaceuticals$121.65-2.1%4.9305 of 5 stars2.80$175.00 43.9%15Insider Selling0.45%HALOHalozyme Therapeutics$45.65-15.4%4.9829 of 5 stars2.60$61.11 33.9%10News CoverageGap DownHigh Trading Volume0.43%CYTKCytokinetics$50.22-8.2%3.8651 of 5 stars2.75$83.67 66.6%16Insider SellingHigh Trading Volume0.41%IONSIonis Pharmaceuticals$34.34-7.8%4.2748 of 5 stars2.68$60.65 76.6%19Analyst DowngradeInsider SellingShort Interest ↑News Coverage0.38%RNAAvidity Biosciences$42.18-15.6%2.5235 of 5 stars3.00$63.22 49.9%9Analyst ForecastAnalyst RevisionNews Coverage0.38%NUVLNuvalent$86.88-3.7%3.1126 of 5 stars2.85$112.60 29.6%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.37%BPMCBlueprint Medicines$88.69-7.3%3.0865 of 5 stars2.71$122.11 37.7%21Analyst ForecastShort Interest ↑News Coverage0.36%KRYSKrystal Biotech$170.74-3.7%4.7831 of 5 stars3.00$197.00 15.4%90.35%RAREUltragenyx Pharmaceutical$44.75-6.1%4.6312 of 5 stars2.92$86.69 93.7%13Analyst Forecast0.33%MDGLMadrigal Pharmaceuticals$288.58-4.7%4.3243 of 5 stars2.69$347.33 20.4%13Positive News0.33%CRNXCrinetics Pharmaceuticals$54.72-8.3%3.5574 of 5 stars2.91$70.18 28.3%11Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.32%ACLXArcellx$87.83-7.6%2.8802 of 5 stars3.07$103.08 17.4%14Analyst ForecastInsider SellingShort Interest ↓0.32%BBIOBridgeBio Pharma$23.72-1.6%4.608 of 5 stars2.87$47.57 100.6%15Analyst ForecastAnalyst RevisionNews Coverage0.32%IMVTImmunovant$26.63-5.1%1.6351 of 5 stars3.00$48.10 80.6%11Positive NewsHigh Trading Volume This page (NASDAQ:BIB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts